Journal Information
Vol. 100. Issue S2.
Mirando hacia el futuro en Dermatología Extraordinario del Centenario. Parte II
Pages 32-39 (December 2009)
Vol. 100. Issue S2.
Mirando hacia el futuro en Dermatología Extraordinario del Centenario. Parte II
Pages 32-39 (December 2009)
Full text access
Looking Ahead in Dermatology: Skin and Allergy
Mirando hacia el futuro en dermatología: piel y alergia
Visits
4686
J. Ring
Corresponding author
johannes.ring@lrz.tum.de

Correspondence: Department of Dermatology and Allergology Biederstein, Klinikum rechts der Isar, Technische Universität München, Biedersteiner Str. 29. 80802 Munich. Germany.
, B. Belloni, H. Behrendt
Department of Dermatology and Allergology Biederstein. ZAUM – Zentrum Allergie und Umwelt (Center for Allergy and Environment). Technische Universität München
This item has received
Article information
Abstract

The prevalence of allergic diseases has increased tremendously over the last decades. Clinically they comprise a spectrum of many different conditions caused by specific immunological hypersensitivity in response to a mostly apathogenic substance. Environmental factors such as lack of immune-stimulating contacts (infection, vaccination) and exposure to allergy-enhancing anthropogenic pollutants from tobacco smoke or traffic exhaust particles are suspected to be involved in the increase of allergies. Recently it has been shown that pollens are not only allergen carriers but also secrete highly active proinflammatory lipid mediators, pollen-associated lipid mediators (PALMs), which have proinflammatory and immuno-modulatory capacity that facilitates allergic sensitization of the skin and mucous membranes.

The skin is one of the most important organs where allergic reactions manifest. Many different morphological and physiopathological entities can be observed in the skin that represent all kinds of pathogenetic immune reactions from immediate-type allergy, urticaria, angioedema, anaphylaxis, cytotoxic and immune complex reactions such as thrombocytopenic purpura or allergic leukocytoclastic vasculitis, exanthematous drug eruptions, granulomatous skin reactions to tattoos or fillers as well as a wide spectrum of dermatitis and eczema with allergic contact dermatitis being one of the most common occupational diseases in many countries.

Recent progress in pathophysiology has revealed a role of epidermal barrier function as well as immunodeviation in atopic eczema giving rise to new diagnostic and therapeutic strategies.

The interdisciplinary character of allergy implies a close cooperation between different disciplines where dermatology plays a major role in the management of allergic diseases, covering diagnostic, therapeutic and preventive aspects.

Key words:
allergy
allergic skin disease
urticaria
angioedema
anaphylaxis
purpura
vasculitis
contact dermatitis
atopic eczema
drug eruptions
granulomatous reactions
Resumen

La prevalencia de las enfermedades alérgicas ha aumentado tremendamente en las últimas décadas. Clínicamente abarcan un espectro de diferentes entidades que están causadas por una hipersensibilidad inmunológica específica como respuesta a una sustancia, en general, no patógena. Se sospecha que el aumento de las alergias se debe a factores ambientales como la falta de contactos que estimulen el sistema inmunitario (infección, vacunas) y la exposición a contaminantes antropogénicos que intensifican las alergias como el humo del tabaco o las partículas de combustión. Recientemente se ha demostrado que los pólenes no son solo portadores de alérgenos, sino que también segregan mediadores lipídicos altamente proinflamatorios, mediadores lipídicos asociados al pólen (siglas en inglés PALM), que facilitan la sensibilización alérgica de la piel y las membrabas mucosas por su capacidad proinflamatoria e inmunomoduladora.

La piel es uno de los órganos más importantes donde se manifiestan las reacciones alérgicas. En la piel se pueden observar diferentes entidades morfológicas y fisiopatológicas que representan todos los tipos de reacciones inmunitarias patogénicas desde alergia inmediata, urticaria, angioedema, anafilaxia, reacciones citotóxicas y mediadas por inmunocomplejos como la púrpura trombocitopénica o la vasculitis leucocitoclástica, toxicodermias exantemáticas, reacciones cutáneas granulomatosas por tatuajes o rellenos así como un amplio espectro de dermatitis y eccema, siendo la dermatitis alérgica de contacto una de las enfermedades profesionales más frecuentes en muchos países.

Los recientes avances en la fisiopatología han revelado un rol de la función de la barrera epidérmica así como una desviación inmunitaria en el eccema atópico, lo que da lugar a nuevas estrategias diagnósticas y terapéuticas.

El carácter interdisciplinar de la alergia implica una estrecha colaboración entre diferentes disciplinas donde la dermatología tiene un papel principal tanto en el diagnóstico, el tratamiento como en la prevención de las enfermedades alérgicas.

Palabras clave:
alergia
enfermedad alérgica cutánea
urticaria
angioedema
anafilaxia
púrpura
vasculitis
dermatitis de contacto
eccema atópico
toxicodermias
reacciones granulomatosas
Full text is only aviable in PDF
References
[1.]
J. Ring.
1st description of an “atopic family anamnesis” in the Julio-Claudian imperial house: Augustus, Claudius, Britannicus.
Hautarzt, 36 (1985), pp. 470-471
[2.]
Pirquet C. Allergie. Münchner Medizinische Wochenschrift. 1906;30:1457.
[3.]
J. Ring.
Allergy in practice.
Springer Verlag, (2005),
[4.]
B. Gassner-Bachmann, B Wüthrich.
Bauernkinder leiden selten an Heuschnupfen und Asthma.
Deutsche Medizinische Wochenschrift, 125 (2000), pp. 924-931
[5.]
C. Braun-Fahrländer, M. Gassner, L. Grize, U. Neu, F.H. Sennhauser, H.S. Varonier, et al.
Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community. SCARPOL team. Swiss Study on Childhood Allergy and Respiratory Symptoms with Respect to Air Pollution.
Clin Exp Allergy, 29 (1999), pp. 28-34
[6.]
J. Riedler, W. Eder, G. Oberfeld, M. Schreuer.
Austrian children living on a farm have less hay fever, asthma and allergic sensitization.
Clin Exp Allergy, 30 (2000), pp. 194-200
[7.]
T. Schäfer, E. Bohler, S. Ruhdorfer, L. Weigl, D. Wessner, B. Filipiak, et al.
Epidemiology of contact allergy in adults.
Allergy, 56 (2001), pp. 1192-1196
[8.]
J. Ring.
100 years ago in the MMW: the birth of allergy. An overview from the beginnings to molecular therapy.
MMW Fortschr Med, 148 (2006), pp. 23-24
[9.]
U. Krämer, C.H. Lemmen, H. Behrendt, E. Link, T. Schäfer, J. Gostomzyk, et al.
The effect of environmental tobacco smoke on eczema and allergic sensitization in children.
Br J Dermatol, 150 (2004), pp. 111-118
[10.]
B. Eberlein-König, B. Przybilla, P. Kuhnl, J. Pechak, I. Gebefügi, J. Kleinschmidt, et al.
Influence of airborne nitrogen dioxide or formaldehyde on parameters of skin function and cellular activation in patients with atopic eczema and control subjects.
J Allergy Clin Immunol, 101 (1998), pp. 141-143
[11.]
J. Huss-Marp, K. Brockow, U. Darsow, F. Pfab, U. Krämer, J. Ring, et al.
Exposure of grass pollen to volatile organic compounds enhances skin prick test reactivity.
J Investig Allergol Clin Immunol, 18 (2008), pp. 408-409
[12.]
U. Krämer, T. Koch, U. Ranft, J. Ring, H. Behrendt.
Traffic-related air pollution is associated with atopy in children living in urban areas.
Epidemiology, 11 (2000), pp. 64-70
[13.]
V. Morgenstern, A. Zutavern, J. Cyrys, I. Brockow, S. Koletzko, U. Krämer, et al.
Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children.
Am J Respir Crit Care Med, 177 (2008), pp. 1331-1337
[14.]
D. Díaz-Sánchez, A.R. Dotson, H. Takenaka, A. Saxon.
Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms.
J Clin Invest, 94 (1994), pp. 1417-1425
[15.]
T. Miyamoto, S. Takafuji.
Environment and allergy.
New Trends in Allergy III, pp. 459-468
[16.]
H. Behrendt, A. Kasche, C. Ebner von Eschenbach, U. Risse, J. Huss-Marp, J. Ring.
Secretion of proinflammatory eicosanoid-like substances precedes allergen release from pollen grains in the initiation of allergic sensitization.
Int Arch Allergy Immunol, 124 (2001), pp. 121-125
[17.]
S.G. Plötz, C. Traidl-Hoffmann, I. Feussner, A. Kasche, A. Feser, J. Ring, et al.
Chemotaxis and activation of human peripheral blood eosinophils induced by pollen-associated lipid mediators.
J Allergy Clin Immunol, 113 (2004), pp. 1152-1160
[18.]
C. Traidl-Hoffmann, V. Mariani, H. Hochrein, K. Karg, H. Wagner, J. Ring, et al.
Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization.
J Exp Med, 201 (2005), pp. 627-636
[19.]
J. Ring, U. Darsow.
Idiopathic anaphylaxis.
Curr Allergy Asthma Rep, 2 (2002), pp. 40-45
[20.]
K. Palosuo, H. Alenius, E. Varjonen, M. Koivuluhta, J. Mikkola, H. Keskinen, et al.
A novel wheat gliadin as a cause of exercise-induced anaphylaxis.
J Allergy Clin Immunol, 103 (1999), pp. 912-917
[21.]
K. Brockow, C. Jofer, H. Behrendt, J. Ring.
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
[22.]
R.A. Sabroe, C.E. Grattan, D.M. Francis, R.M. Barr, A. Kobza Black, M.W. Greaves.
The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria.
Br J Dermatol, 140 (1999), pp. 446-452
[23.]
C.J. Dannaker, H.I. Maibach, M. O’Malley.
Contact urticaria and anaphylaxis to the fungicide chlorothalonil.
Cutis, 52 (1993), pp. 312-315
[24.]
Gutermuth J, Haug S, Ollert M, Darsow U, Ring J, Jakob T. Recurrent skin rash in a 61-year-old house wife. Edited by: www.eaaci.net; 2006.
[25.]
J. Jadassohn.
Zur Kenntnis der Arzneiexantheme.
Arch Derm Syph, (1896), pp. 34
[26.]
C.L. Goh.
Comparative study of TRUE Test and Finn Chamber patch test techniques in Singapore.
Contact Dermatitis, 27 (1992), pp. 84-89
[27.]
P. Hausermann, T. Harr, A.J. Bircher.
Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?.
Contact Dermatitis, 51 (2004), pp. 297-310
[28.]
W.J. Pichler, A. Beeler, M. Keller, M. Lerch, S. Posadas, D. Schmid, et al.
Pharmacological interaction of drugs with immune receptors: the p-i concept.
Allergol Int, 55 (2006), pp. 17-25
[29.]
K. Brockow, C. Christiansen, G. Kanny, O. Clement, A. Barbaud, A. Bircher, et al.
Management of hypersensitivity reactions to iodinated contrast media.
[30.]
W.O. Cookson, M.F. Moffatt.
Genetics of asthma and allergic disease.
Hum Mol Genet, 9 (2000), pp. 2359-2364
[31.]
F.J. Smith, A.D. Irvine, A. Terron-Kwiatkowski, A. Sandilands, L.E. Campbell, Y. Zhao, et al.
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris.
Nat Genet, 38 (2006), pp. 337-342
[32.]
S. Weidinger, H. Baurecht, S. Wagenpfeil, J. Henderson, N. Novak, A. Sandilands, et al.
Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk.
J Allergy Clin Immunol, 122 (2008), pp. 560-568
[33.]
E. Rodríguez, H. Baurecht, E. Herberich, S. Wagenpfeil, S.J. Brown, H.J. Cordell, A.D. Irvine, S. Weidinger.
Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease.
J Allergy Clin Immunol, 123 (2009), pp. 1361-1370
[34.]
S. Kissling, B. Wüthrich.
Follow-up of atopic dermatitis after early childhood.
Hautarzt, 44 (1993), pp. 569-573
[35.]
M. Worm, K. Forschner, H.H. Lee, C.C. Roehr, G. Edenharter, B. Niggemann, et al.
Frequency of atopic dermatitis and relevance of food allergy in adults in Germany.
Acta Derm Venereol, 86 (2006), pp. 119-122
[36.]
M. Möhrenschlager, J. Ring.
Atopic eczema.
Curr Allergy Asthma Rep, 6 (2006), pp. 445-447
[37.]
J. Ring, U. Darsow, M. Gfesser, D. Vieluf.
The ‘atopy patch test’ in evaluating the role of aeroallergens in atopic eczema.
Int Arch Allergy Immunol, 113 (1997), pp. 379-383
[38.]
U. Darsow, D. Vieluf, J. Ring.
Atopy patch test with different vehicles and allergen concentrations: an approach to standardization.
J Allergy Clin Immunol, 95 (1995), pp. 677-684
[39.]
U. Darsow, A. Drzezga, M. Frisch, F. Munz, F. Weilke, P. Bartenstein, et al.
Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions.
J Invest Dermatol, 115 (2000), pp. 1029-1033
[40.]
J. Ring, E. Palos.
Psychosomatic aspects of parent-child relations in atopic eczema in childhood. II. Child-rearing style, the family situation in a drawing test and structured interview.
Hautarzt, 37 (1986), pp. 609-617
[41.]
A. Bockelbrink, J. Heinrich, I. Schäfer, A. Zutavern, M. Borte, O. Herbarth, et al.
Atopic eczema in children: another harmful sequel of divorce.
[42.]
D. Staab, T.L. Diepgen, M. Fartasch, J. Kupfer, T. Lob-Corzilius, J. Ring, et al.
Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial.
[43.]
B. Belloni, M. Ziai, A. Lim, B. Lemercier, M. Sbornik, S. Weidinger, et al.
Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.
J Allergy Clin Immunol, 120 (2007), pp. 1223-1225
[44.]
A. Lim, S. Luderschmidt, A. Weidinger, C. Schnopp, J. Ring, R. Hein, et al.
The IgE repertoire in PBMCs of atopic patients is characterized by individual rearrangements without variable region of the heavy immunoglobulin chain bias.
J Allergy Clin Immunol, 120 (2007), pp. 696-706
[45.]
J.M. Oldhoff, U. Darsow, T. Werfel, K. Katzer, A. Wulf, J. Laifaoui, et al.
Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.
[46.]
S.G. Plötz, H.U. Simon, U. Darsow, D. Simon, E. Vassina, S. Yousefi, et al.
Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis.
N Engl J Med, 349 (2003), pp. 2334-2339
[47.]
J.K. Garrett, S.C. Jameson, B. Thomson, M.H. Collins, L.E. Wagoner, D.K. Freese, et al.
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.
J Allergy Clin Immunol, 113 (2004), pp. 115-119
[48.]
D. Simon, J. Wittwer, G. Kostylina, U. Buettiker, H.U. Simon, N. Yawalkar.
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema.
J Allergy Clin Immunol, 122 (2008), pp. 423-424
[49.]
D. Simon, S. Hosli, G. Kostylina, N. Yawalkar, H.U. Simon.
Anti-CD20 (rituximab) treatment improves atopic eczema.
J Allergy Clin Immunol, 121 (2008), pp. 122-128
Copyright © 2009. Academia Española de Dermatología y Venereología
Download PDF
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?